REFERENCES 1SarwarH, ChapmanWH3rd, PenderJR,
What makes this treatment unique is its enhanced appetite regulation capabilities
In summary, successfully appealing a denial of coverage requires thorough evidence, open communication, and timely submission of a well-crafted appeal letter with all necessary supporting documents
They will likely want to: Review your complete medication list to identify potential interactions with other drugs you are taking Assess your diabetes status and current glycaemic control if you have type 2 diabetes Evaluate your tolerance of Wegovy to date, particularly regarding gastrointestinal side effects Discuss your treatment goals and whether berberine is likely to provide meaningful additional benefit Establish a monitoring plan if you proceed with the combination For people with type 2 diabetes and existing diabetic retinopathy, healthcare professionals may recommend appropriate eye monitoring when starting treatments that can rapidly improve glycaemic control, as this can sometimes temporarily worsen retinopathy
2013 Dec;115 Suppl 1:S86-9
Semaglutide was initially made to help manage type 2 diabetes, but it has now received FDA approval for weight loss and is marketed as Wegovy